Predstanormix Duo: A New Domestic Combination Drug for Treating Lower Urinary Tract Dysfunction Symptoms Associated with BPH

    А.В. Сивков, V.V. Romikh
    Image of study
    TLDR Predstanormix Duo is a safe and effective new drug for treating urinary symptoms from BPH.
    The study introduces Predstanormix Duo, a new domestic combination drug for treating lower urinary tract dysfunction symptoms associated with benign prostatic hyperplasia (BPH). This drug combines dutasteride and tamsulosin in modified-release capsules and has been shown to be bioequivalent to existing treatments. The research involved three groups of comparative clinical studies, demonstrating the drug's high safety and bioequivalence with calculated 90% confidence intervals for pharmacokinetic parameters. Predstanormix Duo is expected to enhance treatment accessibility, improve patient adherence, and offer economic benefits for long-term use.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community I bought 72 packages of Dutasteride

      in Chat  113 upvotes 11 months ago
      A user traveled to Turkey to buy 72 packages of Dutasteride for a year-long supply and successfully brought them back home. They plan to use 2.5mg of Dutasteride daily along with RU58841 for hair loss.

      community Can i use a dut with tamsulosin?

      in Product  3 upvotes 7 months ago
      The conversation is about using a product containing dutasteride and tamsulosin for hair loss. Users discuss separating the components and potential side effects like frequent urination and changes in libido.

      community 7 years finasteride + 2 year dutasteride - Experience

      in Progress Pictures  15 upvotes 1 year ago
      A 35-year-old started finasteride in 2014 for hair loss and maintained hair density for 7 years, occasionally using ketoconazole shampoo. Switched to dutasteride in 2022 due to increased hair fall, experimented with dosages, and found a combination with tamsulosin effective despite initial adverse reactions.

    Related Research

    4 / 4 results